{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:52:59Z","timestamp":1781545979289,"version":"3.54.5"},"posted":{"date-parts":[[2026,6,15]]},"group-title":"In Review","reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,5]]},"abstract":"<title>Abstract<\/title>\n                <p>A chromosomal rearrangement that causes aberrant expression of the ERG transcription factor is the most common genomic alteration in prostate cancer. Expression of ERG in prostate cells can promote either luminal epithelial or mesenchymal cell fates depending on the status of the PI3K\/AKT signaling pathway. Phosphorylation of ERG by ERK is important for oncogenic activity and can be regulated by the TLR4 signaling pathway. Here we found that the PI3K\/AKT pathway not only regulated how ERG promoted distinct cell types within prostate cells, but also altered the positive-feedback loops that drove ERG phosphorylation. Activation of AKT signaling switched the upstream pathway that promotes ERG phosphorylation from TLR4 to VEGF. Inhibition of the PI3K\/AKT pathway in ERG-positive prostate cells resulted in loss of androgen receptor expression, gain of mesenchymal markers and loss of sensitivity to androgen receptor inhibition. Further, androgen depletion reduced PI3K\/AKT activity while increasing MEK\/ERK activity and relative ERG phosphorylation. In a xenograft model, single agent inhibition of TLR4 or VEGFA reduced ERG phosphorylation, tumor size, and luminal marker expression but increased mesenchymal marker expression. Combination TLR4\/VEGFA inhibition reduced tumor size and reduced both luminal and mesenchymal markers. These findings suggest novel combinatorial treatments for ERG-positive prostate cancer.<\/p>","DOI":"10.21203\/rs.3.rs-9941989\/v1","type":"posted-content","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:06:26Z","timestamp":1781543186000},"source":"Crossref","is-referenced-by-count":0,"title":["ERG function in prostate cells is regulated by distinct positive feedback loops depending on AKT signaling status"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1995-0028","authenticated-orcid":false,"given":"Peter","family":"Hollenhorst","sequence":"first","affiliation":[{"name":"Indiana University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Golditch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Kinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Downing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth P.","family":"Nephew","sequence":"additional","affiliation":[{"name":"Indiana University Melvin and Bren Simon Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor BS","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al. Integrative genomic profiling of human prostate cancer. Cancer cell 2010; 18: 11\u201322.","journal-title":"Cancer cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins SA","year":"2005","unstructured":"Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310: 644\u2013648.","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ng.371","article-title":"Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis","volume":"41","author":"King JC","year":"2009","unstructured":"King JC, Xu J, Wongvipat J, Hieronymus H, Carver BS, Leung DH et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat Genet 2009; 41: 524\u2013526.","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1073\/pnas.0905931106","article-title":"ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells","volume":"106","author":"Zong Y","year":"2009","unstructured":"Zong Y, Xin L, Goldstein AS, Lawson DA, Teitell MA, Witte ON. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proc Natl Acad Sci U S A 2009; 106: 12465\u201312470.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ng.370","article-title":"Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate","volume":"41","author":"Carver BS","year":"2009","unstructured":"Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 2009; 41: 619\u2013624.","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1101\/gad.17546311","article-title":"Oncogenic ETS proteins mimic activated RAS\/MAPK signaling in prostate cells","volume":"25","author":"Hollenhorst PC","year":"2011","unstructured":"Hollenhorst PC, Ferris MW, Hull MA, Chae H, Kim S, Graves BJ. Oncogenic ETS proteins mimic activated RAS\/MAPK signaling in prostate cells. Genes & development 2011; 25: 2147\u20132157.","journal-title":"Genes & development"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"25115","DOI":"10.18632\/oncotarget.15931","article-title":"TMPRSS2:ERG gene fusion variants induce TGF-beta signaling and epithelial to mesenchymal transition in human prostate cancer cells","volume":"8","author":"Ratz L","year":"2017","unstructured":"Ratz L, Laible M, Kacprzyk LA, Wittig-Blaich SM, Tolstov Y, Duensing S et al. TMPRSS2:ERG gene fusion variants induce TGF-beta signaling and epithelial to mesenchymal transition in human prostate cancer cells. Oncotarget 2017; 8: 25115\u201325130.","journal-title":"Oncotarget"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e21650","DOI":"10.1371\/journal.pone.0021650","article-title":"TMPRSS2\/ERG promotes epithelial to mesenchymal transition through the ZEB1\/ZEB2 axis in a prostate cancer model","volume":"6","author":"Leshem O","year":"2011","unstructured":"Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R et al. TMPRSS2\/ERG promotes epithelial to mesenchymal transition through the ZEB1\/ZEB2 axis in a prostate cancer model. PloS one 2011; 6: e21650.","journal-title":"PloS one"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1158\/1078-0432.CCR-18-0653","article-title":"TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53-Mutated Prostate Cancer","volume":"24","author":"Blee AM","year":"2018","unstructured":"Blee AM, He Y, Yang Y, Ye Z, Yan Y, Pan Y et al. TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53-Mutated Prostate Cancer. Clin Cancer Res 2018; 24: 4551\u20134565.","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1172\/JCI137967","article-title":"ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming","volume":"130","author":"Li F","year":"2020","unstructured":"Li F, Yuan Q, Di W, Xia X, Liu Z, Mao N et al. ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming. The Journal of clinical investigation 2020; 130: 5924\u20135941.","journal-title":"The Journal of clinical investigation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1009708","DOI":"10.1371\/journal.pgen.1009708","article-title":"Ras\/ERK and PI3K\/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells","volume":"17","author":"Strittmatter BG","year":"2021","unstructured":"Strittmatter BG, Jerde TJ, Hollenhorst PC. Ras\/ERK and PI3K\/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells. PLoS genetics 2021; 17: e1009708.","journal-title":"PLoS genetics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1074\/jbc.M117.796458","article-title":"Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2, allowing target gene activation","volume":"292","author":"Kedage V","year":"2017","unstructured":"Kedage V, Strittmatter BG, Dausinas PB, Hollenhorst PC. Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2, allowing target gene activation. The Journal of biological chemistry 2017; 292: 17225\u201317235.","journal-title":"The Journal of biological chemistry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1541-7786.MCR-25-0389","article-title":"PRC2\/FOXO1-Mediated Repression Determines Interchangeability of ETS Oncogenes in Prostate Cancer and Ewing Sarcoma","volume":"24","author":"Downing NF","year":"2026","unstructured":"Downing NF, Mills KM, Hollenhorst PC. PRC2\/FOXO1-Mediated Repression Determines Interchangeability of ETS Oncogenes in Prostate Cancer and Ewing Sarcoma. Molecular cancer research: MCR 2026; 24: 48\u201359.","journal-title":"Molecular cancer research: MCR"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"zcaa046","DOI":"10.1093\/narcan\/zcaa046","article-title":"Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target","volume":"3","author":"Greulich BM","year":"2021","unstructured":"Greulich BM, Plotnik JP, Jerde TJ, Hollenhorst PC. Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target. NAR Cancer 2021; 3: zcaa046.","journal-title":"NAR Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.celrep.2016.10.001","article-title":"An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer","volume":"17","author":"Kedage V","year":"2016","unstructured":"Kedage V, Selvaraj N, Nicholas TR, Budka JA, Plotnik JP, Jerde TJ et al. An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer. Cell Rep 2016; 17: 1289\u20131301.","journal-title":"Cell Rep"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2007.03.052","article-title":"Integrative genomic approaches identify IKBKE as a breast cancer oncogene","volume":"129","author":"Boehm JS","year":"2007","unstructured":"Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007; 129: 1065\u20131079.","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12964-015-0089-7","article-title":"Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells","volume":"13","author":"Selvaraj N","year":"2015","unstructured":"Selvaraj N, Kedage V, Hollenhorst PC. Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells. Cell communication and signaling: CCS 2015; 13: 12.","journal-title":"Cell communication and signaling: CCS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3389\/fimmu.2018.02434","article-title":"Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis","volume":"9","author":"Bhattacharyya S","year":"2018","unstructured":"Bhattacharyya S, Wang W, Tamaki Z, Shi B, Yeldandi A, Tsukimi Y et al. Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis. Front Immunol 2018; 9: 2434.","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1158\/0008-5472.CAN-20-3562","article-title":"LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer","volume":"81","author":"Miller SA","year":"2021","unstructured":"Miller SA, Policastro RA, Sriramkumar S, Lai T, Huntington TD, Ladaika CA et al. LSD1 and Aberrant DNA Methylation Mediate Persistence of Enteroendocrine Progenitors That Support BRAF-Mutant Colorectal Cancer. Cancer Res 2021; 81: 3791\u20133805.","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41588-020-0642-1","article-title":"Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips","volume":"52","author":"Guo W","year":"2020","unstructured":"Guo W, Li L, He J, Liu Z, Han M, Li F et al. Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips. Nat Genet 2020; 52: 908\u2013918.","journal-title":"Nat Genet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/path.4924","article-title":"A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours","volume":"243","author":"Sackmann Sala L","year":"2017","unstructured":"Sackmann Sala L, Boutillon F, Menara G, De Goyon-Pelard A, Leprevost M, Codzamanian J et al. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours. J Pathol 2017; 243: 51\u201364.","journal-title":"J Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tiv.2019.05.023","article-title":"A human-derived prostate co-culture microtissue model using epithelial (RWPE-1) and stromal (WPMY-1) cell lines","volume":"60","author":"Dent MP","year":"2019","unstructured":"Dent MP, Madnick SJ, Hall S, Vantangoli Policelli M, Bars C, Li H et al. A human-derived prostate co-culture microtissue model using epithelial (RWPE-1) and stromal (WPMY-1) cell lines. Toxicol In Vitro 2019; 60: 203\u2013211.","journal-title":"Toxicol In Vitro"},{"key":"ref23","first-page":"2428","article-title":"Dynamic regulation of VEGF-inducible genes by an ERK\/ERG\/p300 transcriptional network","volume":"144","author":"Fish JE","year":"2017","unstructured":"Fish JE, Cantu Gutierrez M, Dang LT, Khyzha N, Chen Z, Veitch S et al. Dynamic regulation of VEGF-inducible genes by an ERK\/ERG\/p300 transcriptional network. Development 2017; 144: 2428\u20132444.","journal-title":"Development"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41467-022-29655-0","article-title":"Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors","volume":"13","author":"Savill KMZ","year":"2022","unstructured":"Savill KMZ, Lee BB, Oeh J, Lin J, Lin E, Chung WJ et al. Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors. Nature communications 2022; 13: 2057.","journal-title":"Nature communications"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"21750","DOI":"10.1038\/s41598-020-78798-x","article-title":"Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease","volume":"10","author":"Smith R","year":"2020","unstructured":"Smith R, Liu M, Liby T, Bayani N, Bucher E, Chiotti K et al. Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease. Sci Rep 2020; 10: 21750.","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-16-2169","article-title":"Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial-Mesenchymal Plasticity in Prostate Cancer","volume":"77","author":"Miao L","year":"2017","unstructured":"Miao L, Yang L, Li R, Rodrigues DN, Crespo M, Hsieh JT et al. Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial-Mesenchymal Plasticity in Prostate Cancer. Cancer Res 2017; 77: 3101\u20133112.","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e3007","DOI":"10.1038\/cddis.2017.417","article-title":"Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-beta1\/STAT3 axis-regulated EMT","volume":"8","author":"Liu Q","year":"2017","unstructured":"Liu Q, Tong D, Liu G, Xu J, Do K, Geary K et al. Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-beta1\/STAT3 axis-regulated EMT. Cell Death Dis 2017; 8: e3007.","journal-title":"Cell Death Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque MP","year":"2019","unstructured":"Labrecque MP, Coleman IM, Brown LG, True LD, Kollath L, Lakely B et al. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. The Journal of clinical investigation 2019; 129: 4492\u20134505.","journal-title":"The Journal of clinical investigation"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1158\/0008-5472.CAN-23-0593","article-title":"The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer","volume":"83","author":"Lundberg A","year":"2023","unstructured":"Lundberg A, Zhang M, Aggarwal R, Li H, Zhang L, Foye A et al. The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer. Cancer Res 2023; 83: 2763\u20132774.","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"110595","DOI":"10.1016\/j.celrep.2022.110595","article-title":"Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis","volume":"39","author":"Han H","year":"2022","unstructured":"Han H, Wang Y, Curto J, Gurrapu S, Laudato S, Rumandla A et al. Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis. Cell Rep 2022; 39: 110595.","journal-title":"Cell Rep"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"105398","DOI":"10.1016\/j.ebiom.2024.105398","article-title":"Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression","volume":"109","author":"Zhao F","year":"2024","unstructured":"Zhao F, Zhang T, Wei J, Chen L, Liu Z, Jin Y et al. Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression. EBioMedicine 2024; 109: 105398.","journal-title":"EBioMedicine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","article-title":"Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance","volume":"6","author":"Ge R","year":"2022","unstructured":"Ge R, Wang Z, Cheng L. Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance. NPJ Precis Oncol 2022; 6: 31.","journal-title":"NPJ Precis Oncol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9941989\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9941989\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:06:31Z","timestamp":1781543191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9941989\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":32,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9941989\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,6,15]]},"subtype":"preprint"}}